rs113190032

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_017534.6(MYH2):ā€‹c.2967A>Gā€‹(p.Ala989=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00197 in 1,610,484 control chromosomes in the GnomAD database, including 88 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā˜…ā˜…).

Frequency

Genomes: š‘“ 0.010 ( 40 hom., cov: 32)
Exomes š‘“: 0.0011 ( 48 hom. )

Consequence

MYH2
NM_017534.6 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -0.748
Variant links:
Genes affected
MYH2 (HGNC:7572): (myosin heavy chain 2) Myosins are actin-based motor proteins that function in the generation of mechanical force in eukaryotic cells. Muscle myosins are heterohexamers composed of 2 myosin heavy chains and 2 pairs of nonidentical myosin light chains. This gene encodes a member of the class II or conventional myosin heavy chains, and functions in skeletal muscle contraction. This gene is found in a cluster of myosin heavy chain genes on chromosome 17. A mutation in this gene results in inclusion body myopathy-3. Multiple alternatively spliced variants, encoding the same protein, have been identified. [provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BP6
Variant 17-10529714-T-C is Benign according to our data. Variant chr17-10529714-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 285372.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.748 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0103 (1553/150984) while in subpopulation AFR AF= 0.0343 (1387/40402). AF 95% confidence interval is 0.0328. There are 40 homozygotes in gnomad4. There are 753 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 40 SD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
MYH2NM_017534.6 linkuse as main transcriptc.2967A>G p.Ala989= synonymous_variant 24/40 ENST00000245503.10 NP_060004.3
MYHASNR_125367.1 linkuse as main transcriptn.168-37823T>C intron_variant, non_coding_transcript_variant
MYH2NM_001100112.2 linkuse as main transcriptc.2967A>G p.Ala989= synonymous_variant 24/40 NP_001093582.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
MYH2ENST00000245503.10 linkuse as main transcriptc.2967A>G p.Ala989= synonymous_variant 24/401 NM_017534.6 ENSP00000245503 P1Q9UKX2-1
ENST00000399342.6 linkuse as main transcriptn.207-3610T>C intron_variant, non_coding_transcript_variant 3

Frequencies

GnomAD3 genomes
AF:
0.0102
AC:
1539
AN:
150878
Hom.:
39
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0341
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00532
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00798
Gnomad SAS
AF:
0.00104
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000412
Gnomad OTH
AF:
0.00482
GnomAD3 exomes
AF:
0.00181
AC:
454
AN:
250272
Hom.:
18
AF XY:
0.00135
AC XY:
183
AN XY:
135352
show subpopulations
Gnomad AFR exome
AF:
0.0225
Gnomad AMR exome
AF:
0.00128
Gnomad ASJ exome
AF:
0.0000992
Gnomad EAS exome
AF:
0.000554
Gnomad SAS exome
AF:
0.000458
Gnomad FIN exome
AF:
0.0000462
Gnomad NFE exome
AF:
0.000264
Gnomad OTH exome
AF:
0.000491
GnomAD4 exome
AF:
0.00111
AC:
1613
AN:
1459500
Hom.:
48
Cov.:
34
AF XY:
0.000994
AC XY:
722
AN XY:
726136
show subpopulations
Gnomad4 AFR exome
AF:
0.0275
Gnomad4 AMR exome
AF:
0.00186
Gnomad4 ASJ exome
AF:
0.0000383
Gnomad4 EAS exome
AF:
0.00339
Gnomad4 SAS exome
AF:
0.000696
Gnomad4 FIN exome
AF:
0.000112
Gnomad4 NFE exome
AF:
0.000280
Gnomad4 OTH exome
AF:
0.00188
GnomAD4 genome
AF:
0.0103
AC:
1553
AN:
150984
Hom.:
40
Cov.:
32
AF XY:
0.0102
AC XY:
753
AN XY:
73846
show subpopulations
Gnomad4 AFR
AF:
0.0343
Gnomad4 AMR
AF:
0.00531
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00800
Gnomad4 SAS
AF:
0.00104
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000412
Gnomad4 OTH
AF:
0.00477
Alfa
AF:
0.00440
Hom.:
6
Bravo
AF:
0.0164

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingGeneDxOct 16, 2019- -
Benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenMay 01, 2024MYH2: BP4, BP7, BS1, BS2 -
Myopathy, proximal, and ophthalmoplegia Benign:3
Likely benign, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsJan 13, 2022- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 19, 2024- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
not specified Benign:1
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Dec 22, 2015- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.54
CADD
Benign
3.3
DANN
Benign
0.81

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs113190032; hg19: chr17-10433031; COSMIC: COSV55433879; API